The global blood market is projected to register a CAGR of 4.16 %, generating an anticipated revenue of $3730.77 million, by 2028. The base year considered for the market study is 2018, and the forecast years are from 2019 to 2028. Blood is among the most valuable and expensive resources in the world, and individuals suffering from injuries and viral infections require a blood transfusion. As a result, patients are either given whole blood or blood components for quick recovery and to accelerate the healing process.
GLOBAL BLOOD MARKET FORECAST 2019-2028
Global Blood Market by Product (Whole Blood Collection (Whole Blood Collection Systems, Whole Blood Collection Reagents), Source Plasma Collection (Source Plasma Collection Systems, Source Plasma Collection Reagents), Blood Therapeutics (Intravenous Immunoglobulin (Ivig),albumin, Hyperimmune, Factor Viii, Factor Ix, Other Blood Therapeutics), Blood Typing (Blood Typing Systems, Blood Typing Reagents), Blood Screening (Blood Screening Systems, Blood Screening Reagents), Blood Processing Equipment (Blood Processing Equipment Systems, Blood Processing Equipment Reagents)) by End-user (Blood & Blood Component Banks, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, Other End-users) and by Geography.
The global blood market is projected to register a CAGR of 4.16 %, generating an anticipated revenue of $9164.38 million, by 2028. The base year considered for the market study is 2018, and the forecast years are from 2019 to 2028.
Blood is among the most valuable and expensive resources in the world, and individuals suffering from injuries and viral infections require a blood transfusion. As a result, patients are either given whole blood or blood components for quick recovery and to accelerate the healing process.
To know more about this report, request a free sample copy
Key factors propelling the global blood market growth:
- Worldwide increase in the demand for blood and blood-related products
- Surge in the global geriatric population
- Rise in blood donations and plasma donations
- According to the World Health Organization (WHO), nearly 117.4 million blood donations are witnessed, annually. The increasing number of blood donations across the globe leads to an upsurge in need of blood collecting reagents and instruments.
- Promising government regulations for blood screening
- Developments in blood transfusion and blood screening instruments
Major factors restraining the global blood market:
- High costs of advanced blood collection devices
- The market’s key players supply sophisticated and automated instruments. These devices implement the apheresis method to collect blood, instead of whole blood collection. However, the instruments are expensive, and hinder the global blood market’s growth.
- For instance, Terumo BCT Inc, a subsidiary of Terumo Corporation, provides an automated blood collection system called Trima Accel, which costs around $36,000. Moreover, the system’s expense excludes the cost of disposables used during the patient’s blood collection. Therefore, the high costs of automated systems minimize their adoption, especially in smaller hospitals and companies, and hinder the market growth.
- Lack of skilled laboratory professionals.
The report scope of the global blood market includes the segmentation analysis based on product and end-user. These segments are further classified to provide a detailed analysis of the market studied.
Market by Product:
- Whole Blood Collection
- Source Plasma Collection
- Source plasma collection is set to be a prominent product by 2028. The plasma collected from a healthy individual through plasmapheresis is termed as source plasma. They are projected to gain prominence in the Asia Pacific region.
- Blood Therapeutics
- Blood therapeutics dominated the product segment in 2019. People suffering from immune disorders, such as primary immunodeficiency, produce insufficient antibodies. As a result, the patients primarily rely on immunoglobulin treatment for controlling their conditions.
- Additionally, awareness among people regarding plasma donation, and the rising number of surgeries, burns, and traumatic conditions boost the market growth for blood therapeutics.
- Blood Typing
- Blood Screening
- Blood Processing Equipment
Geographically, the global blood market has been segmented based on four major regions, which includes:
- North America: The United States and Canada
- North America dominated the global market in 2019. The region’s market benefits from the presence of dominating players, a robust healthcare system, and the growing incidences of chronic diseases.
- Europe: Germany, The United Kingdom, Italy, France, Belgium, Russia, Poland, and Rest of Europe
- Asia Pacific: India, China, Japan, South Korea, Indonesia, Thailand Vietnam, Australia & New Zealand, and Rest of Asia Pacific
- The Asia Pacific is set to be the fastest-growing region by 2028. The increasing number of patients suffering from chronic diseases and improving healthcare facilities in the region offer lucrative opportunities for key players within the blood collection equipment sector.
- Rest of World: Latin America, the Middle East & Africa
Key players in the global blood market:
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- CSL Limited
- Immucor Inc
- Others
Key strategies adopted by companies in the global blood market:
In May 2020, Abbott declared that the United States Food and Drug Administration (FDA) issued the Emergency Use Authorization (EUA), with respect to the enterprise’s COVID-19 molecular test. The EUA would be used on Alinity™ m, the firm’s new molecular laboratory instrument. In March, the U.S. FDA had cleared the Alinity m system for use, along with the company’s Hepatitis C assay (HCV). Abbott is also working with healthcare systems and hospitals in the United States, for the equipment’s installation. Moreover, this is projected to cope with the rising demands for testing.
Key findings of the global blood market:
- The Asia Pacific is anticipated to emerge as the most promising regional market.
- Developing economies, across the world, offer lucrative opportunities for market growth
- The source plasma collection segment is expected to grow with the highest CAGR.
Frequently Asked Questions & Answers (FAQ):
- What is the size of the global blood market?
A: As of 2019, the market size, in terms of revenue, stood at $9164.38 million.
- Which is the fastest-growing end-user?
A: Blood & Blood Component Banks are the fastest-growing end-users.
- What are the top companies operating within the global blood market?
A: Abbott Laboratories, Bio-Rad Laboratories Inc, Immucor Inc, etc. are some of the top companies in the global market.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
- INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
- SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
- RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
- PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
- PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
- KEY RESTRAINTS
- HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
- DEARTH OF SKILLED LABORATORY PROFESSIONALS
- KEY ANALYTICS
- KEY INVESTMENT INSIGHTS
- PORTER’S FIVE FORCE ANALYSIS
- BUYER POWER
- SUPPLIER POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- IMPACT OF COVID – BLOOD MARKET
- MARKET BY PRODUCT
- WHOLE BLOOD COLLECTION
- WHOLE BLOOD COLLECTION SYSTEMS
- WHOLE BLOOD COLLECTION REAGENTS
- SOURCE PLASMA COLLECTION
- SOURCE PLASMA COLLECTION SYSTEMS
- SOURCE PLASMA COLLECTION REAGENTS
- BLOOD THERAPEUTICS
- INTRAVENOUS IMMUNOGLOBULIN (IVIG)
- ALBUMIN
- HYPERIMMUNE
- FACTOR VIII
- FACTOR IX
- OTHER BLOOD THERAPEUTICS
- BLOOD TYPING
- BLOOD TYPING SYSTEMS
- BLOOD TYPING REAGENTS
- BLOOD SCREENING
- BLOOD SCREENING SYSTEMS
- BLOOD SCREENING REAGENTS
- BLOOD PROCESSING EQUIPMENT
- BLOOD PROCESSING EQUIPMENT SYSTEMS
- BLOOD PROCESSING EQUIPMENT REAGENTS
- WHOLE BLOOD COLLECTION
- MARKET BY END-USER
- BLOOD & BLOOD COMPONENT BANKS
- DIAGNOSTIC LABORATORIES
- AMBULATORY SURGICAL CENTERS
- HOSPITALS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- ASIA PACIFIC
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA PACIFIC
- REST OF WORLD
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
- COMPANY PROFILES
- ABBOTT LABORATORIES
- BIO-RAD LABORATORIES INC
- CSL LIMITED (CSL BEHRING)
- F HOFFMANN-LA ROCHE LTD
- GRIFOLS INTERNATIONAL SA
- HAEMONETICS CORPORATION
- MERCK & CO INC
- NOVO NORDISK A/S
- BAXTER INTERNATIONAL INC
- BECTON DICKINSON AND COMPANY
- FRESENIUS KABI AG
- ORTHO CLINICAL DIAGNOSTICS
- TERUMO CORPORATION (TERUMO BCT INC)
- IMMUCOR INC
TABLE LIST
TABLE 1: MARKET SNAPSHOT – BLOOD
TABLE 2: GLOBAL BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL ALBUMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL ALBUMIN SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL HYPERIMMUNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL HYPERIMMUNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL FACTOR VIII MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL FACTOR VIII MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL FACTOR IX MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL FACTOR IX MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL BLOOD TYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL BLOOD TYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL BLOOD SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL BLOOD SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL BLOOD MARKET, BY END-USERS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL BLOOD MARKET, BY END-USERS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 60: GLOBAL BLOOD MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 61: GLOBAL BLOOD MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 62: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 63: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 64: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 65: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 66: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 67: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 68: REST OF WORLD BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 69: REST OF WORLD BLOOD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
FIGURE LIST
FIGURE 1: KEY INVESTMENT INSIGHTS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
FIGURE 6: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)
FIGURE 7: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019
FIGURE 8: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 9: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 10: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)
FIGURE 11: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019
FIGURE 12: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 13: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 14: GLOBAL BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019
FIGURE 16: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 17: GLOBAL BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)
FIGURE 18: GLOBAL BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)
FIGURE 20: GLOBAL BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)
FIGURE 21: GLOBAL BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
FIGURE 22: GLOBAL BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)
FIGURE 23: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019
FIGURE 24: GLOBAL BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 25: GLOBAL BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 26: GLOBAL BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)
FIGURE 27: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019
FIGURE 28: GLOBAL BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 29: GLOBAL BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 30: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)
FIGURE 31: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019
FIGURE 32: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)
FIGURE 33: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 34: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
FIGURE 35: GLOBAL BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)
FIGURE 36: GLOBAL BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)
FIGURE 37: GLOBAL BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
FIGURE 38: GLOBAL BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
FIGURE 39: GLOBAL BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 40: NORTH AMERICA BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 41: UNITED STATES BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 42: CANADA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 43: EUROPE BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 44: UNITED KINGDOM BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 45: GERMANY BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 46: FRANCE BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 47: ITALY BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 48: RUSSIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 49: BELGIUM BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 50: POLAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 51: REST OF EUROPE BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 52: ASIA PACIFIC BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 53: CHINA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 54: JAPAN BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 55: INDIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 56: SOUTH KOREA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 57: INDONESIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 58: THAILAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 59: VIETNAM BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 60: AUSTRALIA & NEW ZEALAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 61: REST OF ASIA PACIFIC BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 62: REST OF WORLD BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 63: LATIN AMERICA BLOOD MARKET, 2019-2028 (IN $ MILLION)
FIGURE 64: MIDDLE EAST & AFRICA BLOOD MARKET, 2019-2028 (IN $ MILLION)
- MARKET BY PRODUCT
- WHOLE BLOOD COLLECTION
- WHOLE BLOOD COLLECTION SYSTEMS
- WHOLE BLOOD COLLECTION REAGENTS
- SOURCE PLASMA COLLECTION
- SOURCE PLASMA COLLECTION SYSTEMS
- SOURCE PLASMA COLLECTION REAGENTS
- BLOOD THERAPEUTICS
- INTRAVENOUS IMMUNOGLOBULIN (IVIG)
- ALBUMIN
- HYPERIMMUNE
- FACTOR VIII
- FACTOR IX
- OTHER BLOOD THERAPEUTICS
- BLOOD TYPING
- BLOOD TYPING SYSTEMS
- BLOOD TYPING REAGENTS
- BLOOD SCREENING
- BLOOD SCREENING SYSTEMS
- BLOOD SCREENING REAGENTS
- BLOOD PROCESSING EQUIPMENT
- BLOOD PROCESSING EQUIPMENT SYSTEMS
- BLOOD PROCESSING EQUIPMENT REAGENTS
- WHOLE BLOOD COLLECTION
- MARKET BY END-USER
- BLOOD & BLOOD COMPONENT BANKS
- DIAGNOSTIC LABORATORIES
- AMBULATORY SURGICAL CENTERS
- HOSPITALS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- ASIA PACIFIC
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA PACIFIC
- REST OF WORLD
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.